Cancer is a serious disease due to deleterious mutations in specific genes that induces the cells to grow in an uncontrolled and abnormal manner, killing normal cells and with the potential to spread to other parts of the body.
When a deleterious mutation is present, a Genoma Early Risk Cancer Screening allows the identification of it and enables tailored treatment strategies best suited for this mutation.
Whereas, current screening procedures for cancer are largely based on radiological models, which detect changes in tissue structures. These changes signal a tumorous process which has already been initiated. The survival rates are quite low.
Genoma develops Early Risk Cancer Screening tests intended to the whole population to enable the most effective preventive actions to be taken before cancer develops to improve survival rates and better quality of life.